Select Medical's 15min chart sees MACD Death Cross, Bollinger Bands narrowing, KDJ Death Cross.
PorAinvest
viernes, 15 de agosto de 2025, 11:59 am ET1 min de lectura
SEM--
The MACD Death Cross indicates a bearish trend reversal, while the KDJ Death Cross signals a shift in market sentiment, with buyers losing their grip on the market. The Bollinger Bands Narrowing further supports this bearish trend by suggesting a decline in the magnitude of price fluctuations [2].
Mizuho Financial Group recently lowered its price target for Select Medical to $18.00 from $21.00, maintaining an Outperform rating. The firm cited disappointing second-quarter 2025 earnings, with particular pressure in the company’s critical illness recovery hospital (LTCH) segment, which continues to face challenges from the Medicare high-cost outlier threshold and the 20% transmittal rule [3].
Despite these challenges, Select Medical’s inpatient rehabilitation (IRF) segment remains a bright spot in the company’s operations. Mizuho expects the IRF segment to continue driving growth for Select Medical, supporting its decision to maintain an Outperform rating despite the reduced price target [3].
Select Medical reported its second-quarter 2025 earnings, showing a mixed performance. The company achieved a significant earnings per share (EPS) of $0.60, which was a substantial 150% above the forecast of $0.24. However, the revenue fell short of expectations, coming in at $1.28 billion compared to the anticipated $1.34 billion [3].
Investors are advised to exercise caution and diligent risk management in the face of these bearish indicators. The market's current state of paralysis, awaiting the quarterly results of ICICI Bank, HDFC Bank, and Reliance Industries, scheduled for release this weekend, may further exacerbate volatility [3].
References:
[1] https://www.ainvest.com/news/nuvalent-15min-chart-shows-macd-death-cross-kdj-death-cross-2508/
[2] https://www.ainvest.com/news/bollinger-bands-narrowing-kdj-death-cross-triggered-champion-homes-15-min-chart-2507/
[3] https://za.investing.com/news/analyst-ratings/mizuho-lowers-select-medical-holdings-stock-price-target-on-ltch-segment-pressure-93CH-3831403
The 15-minute chart for Select Medical's stock has recently triggered a MACD Death Cross, Bollinger Bands Narrowing, and KDJ Death Cross as of August 15, 2025, at 11:45. This indicates that the stock price has the potential to continue falling, with a decreasing magnitude of fluctuations, and a momentum shift towards the downside, potentially leading to further decreases in value.
Select Medical (NYSE: SEM) has recently triggered several bearish indicators on its 15-minute chart, signaling potential further declines in stock price. On August 15, 2025, at 11:45, the stock experienced a MACD Death Cross, Bollinger Bands Narrowing, and KDJ Death Cross. These technical indicators suggest a momentum shift towards the downside, with a decreasing magnitude of price fluctuations [1].The MACD Death Cross indicates a bearish trend reversal, while the KDJ Death Cross signals a shift in market sentiment, with buyers losing their grip on the market. The Bollinger Bands Narrowing further supports this bearish trend by suggesting a decline in the magnitude of price fluctuations [2].
Mizuho Financial Group recently lowered its price target for Select Medical to $18.00 from $21.00, maintaining an Outperform rating. The firm cited disappointing second-quarter 2025 earnings, with particular pressure in the company’s critical illness recovery hospital (LTCH) segment, which continues to face challenges from the Medicare high-cost outlier threshold and the 20% transmittal rule [3].
Despite these challenges, Select Medical’s inpatient rehabilitation (IRF) segment remains a bright spot in the company’s operations. Mizuho expects the IRF segment to continue driving growth for Select Medical, supporting its decision to maintain an Outperform rating despite the reduced price target [3].
Select Medical reported its second-quarter 2025 earnings, showing a mixed performance. The company achieved a significant earnings per share (EPS) of $0.60, which was a substantial 150% above the forecast of $0.24. However, the revenue fell short of expectations, coming in at $1.28 billion compared to the anticipated $1.34 billion [3].
Investors are advised to exercise caution and diligent risk management in the face of these bearish indicators. The market's current state of paralysis, awaiting the quarterly results of ICICI Bank, HDFC Bank, and Reliance Industries, scheduled for release this weekend, may further exacerbate volatility [3].
References:
[1] https://www.ainvest.com/news/nuvalent-15min-chart-shows-macd-death-cross-kdj-death-cross-2508/
[2] https://www.ainvest.com/news/bollinger-bands-narrowing-kdj-death-cross-triggered-champion-homes-15-min-chart-2507/
[3] https://za.investing.com/news/analyst-ratings/mizuho-lowers-select-medical-holdings-stock-price-target-on-ltch-segment-pressure-93CH-3831403
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios